Changing Patterns in Treatment, Remission Status, and Categories in a Long-Term Nordic Cohort Study of Juvenile Idiopathic Arthritis.

Mia B Glerup Ellen Dalen Arnstad Veronika RypdalSuvi PeltoniemiKristiina AaltoMarite RyggSusan NielsenAnders FasthLillemor BerntsonEllen NordalTroels Herlinnull null

Published in: Arthritis care & research (2022)

In this Nordic JIA cohort study, the remission rate did not increase even though significantly more patients were off medication at the 18-year follow-up compared to at the 8-year follow-up after disease onset. The distribution of patients in the ILAR categories continued to change significantly throughout the 18-year study period.

Keyphrases

systemic lupus erythematosus
disease activity
juvenile idiopathic arthritis
end stage renal disease
newly diagnosed
ejection fraction
chronic kidney disease
healthcare
prognostic factors
emergency department
rheumatoid arthritis
patient reported outcomes
adverse drug
electronic health record
smoking cessation